Devyser announces a strengthening of its commercial organization with the appointment of Theis...
May 11, 2022 08:00
Stockholm, February 7, 2022
We are extremely proud to have been recognized, once again, as one of Sweden's Best Workplaces!...
Devyser has been awarded a funding of EUR 750,000 through the Eurostars-2 program and will join its...
Dr. Dan Hauzenberger, Medical Director, Section of Transplantation Immunology at Sweden’s...
We’re happy to announce that we’ve received certification for the successful completion of a...
Devyser welcomes Fredrik Alpsten as new CEO starting September 1st. Ulf Klangby, the former CEO and...
Swedish genetic test developer Devyser’s product for hereditary breast and ovarian cancer (HBOC) is...
From June 1st to June 7th 2020 is World Haemochromatosis Week.
Stockholm, 26 may 2020
